Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

Cortical hubs and subcortical cholinergic pathways as neural substrates of poststroke dementia.

Lim JS, Kim N, Jang MU, Han MK, Kim S, Baek MJ, Jang MS, Ban B, Kang Y, Kim DE, Lee JS, Lee J, Lee BC, Yu KH, Black SE, Bae HJ.

Stroke. 2014 Apr;45(4):1069-76. doi: 10.1161/STROKEAHA.113.004156.

2.

The effect of ischemic cholinergic damage on cognition in patients with subcortical vascular cognitive impairment.

Kim SH, Kang HS, Kim HJ, Moon Y, Ryu HJ, Kim MY, Han SH.

J Geriatr Psychiatry Neurol. 2012 Jun;25(2):122-7. doi: 10.1177/0891988712445089.

PMID:
22689705
3.

Subcortical white matter hyperintensities within the cholinergic pathways of Parkinson's disease patients according to cognitive status.

Shin J, Choi S, Lee JE, Lee HS, Sohn YH, Lee PH.

J Neurol Neurosurg Psychiatry. 2012 Mar;83(3):315-21. doi: 10.1136/jnnp-2011-300872.

PMID:
22228726
4.

How complex interactions of ischemic brain infarcts, white matter lesions, and atrophy relate to poststroke dementia.

Pohjasvaara T, Mäntylä R, Salonen O, Aronen HJ, Ylikoski R, Hietanen M, Kaste M, Erkinjuntti T.

Arch Neurol. 2000 Sep;57(9):1295-300.

PMID:
10987896
5.

Trail Making Test Elucidates Neural Substrates of Specific Poststroke Executive Dysfunctions.

Muir RT, Lam B, Honjo K, Harry RD, McNeely AA, Gao FQ, Ramirez J, Scott CJ, Ganda A, Zhao J, Zhou XJ, Graham SJ, Rangwala N, Gibson E, Lobaugh NJ, Kiss A, Stuss DT, Nyenhuis DL, Lee BC, Kang Y, Black SE.

Stroke. 2015 Oct;46(10):2755-61. doi: 10.1161/STROKEAHA.115.009936.

6.

A new visual rating scale to assess strategic white matter hyperintensities within cholinergic pathways in dementia.

Bocti C, Swartz RH, Gao FQ, Sahlas DJ, Behl P, Black SE.

Stroke. 2005 Oct;36(10):2126-31.

7.

MRI correlates of dementia after first clinical ischemic stroke.

Pohjasvaara T, Mäntylä R, Salonen O, Aronen HJ, Ylikoski R, Hietanen M, Kaste M, Erkinjuntti T.

J Neurol Sci. 2000 Dec 1;181(1-2):111-7.

PMID:
11099720
8.

Differential cholinergic pathway involvement in Alzheimer's disease and subcortical ischemic vascular dementia.

Kim HJ, Moon WJ, Han SH.

J Alzheimers Dis. 2013;35(1):129-36. doi: 10.3233/JAD-122320.

PMID:
23364137
9.

Frontal white matter hyperintensities, clasmatodendrosis and gliovascular abnormalities in ageing and post-stroke dementia.

Chen A, Akinyemi RO, Hase Y, Firbank MJ, Ndung'u MN, Foster V, Craggs LJ, Washida K, Okamoto Y, Thomas AJ, Polvikoski TM, Allan LM, Oakley AE, O'Brien JT, Horsburgh K, Ihara M, Kalaria RN.

Brain. 2016 Jan;139(Pt 1):242-58. doi: 10.1093/brain/awv328.

10.

Abnormal functional connectivity in patients with vascular cognitive impairment, no dementia: a resting-state functional magnetic resonance imaging study.

Sun YW, Qin LD, Zhou Y, Xu Q, Qian LJ, Tao J, Xu JR.

Behav Brain Res. 2011 Oct 1;223(2):388-94. doi: 10.1016/j.bbr.2011.05.006.

PMID:
21605598
11.

Charting cognitive and volumetric trajectories after stroke: protocol for the Cognition And Neocortical Volume After Stroke (CANVAS) study.

Brodtmann A, Werden E, Pardoe H, Li Q, Jackson G, Donnan G, Cowie T, Bradshaw J, Darby D, Cumming T.

Int J Stroke. 2014 Aug;9(6):824-8. doi: 10.1111/ijs.12301.

PMID:
24894387
12.

Gray matter atrophy in patients with ischemic stroke with cognitive impairment.

Stebbins GT, Nyenhuis DL, Wang C, Cox JL, Freels S, Bangen K, deToledo-Morrell L, Sripathirathan K, Moseley M, Turner DA, Gabrieli JD, Gorelick PB.

Stroke. 2008 Mar;39(3):785-93. doi: 10.1161/STROKEAHA.107.507392.

13.

Cholinergic subcortical hyperintensities in Alzheimer's disease patients from the Sunnybrook Dementia Study: relationships with cognitive dysfunction and hippocampal atrophy.

McNeely AA, Ramirez J, Nestor SM, Zhao J, Gao F, Kiss A, Stuss DT, Black SE.

J Alzheimers Dis. 2015;43(3):785-96. doi: 10.3233/JAD-140588.

PMID:
25114078
14.

Study on frequency and predictors of dementia after ischemic stroke: the Chongqing stroke study.

Zhou DH, Wang JY, Li J, Deng J, Gao C, Chen M.

J Neurol. 2004 Apr;251(4):421-7.

PMID:
15083286
15.

Cognitive disorders in acute stroke: prevalence and clinical determinants.

Nys GM, van Zandvoort MJ, de Kort PL, Jansen BP, de Haan EH, Kappelle LJ.

Cerebrovasc Dis. 2007;23(5-6):408-16.

PMID:
17406110
16.

Progression of cognitive impairment in stroke/TIA patients over 3 years.

Sachdev PS, Lipnicki DM, Crawford JD, Wen W, Brodaty H.

J Neurol Neurosurg Psychiatry. 2014 Dec;85(12):1324-30. doi: 10.1136/jnnp-2013-306776.

PMID:
24659793
17.

White matter lesions are related to impaired instrumental activities of daily living poststroke.

Pohjasvaara TI, Jokinen H, Ylikoski R, Kalska H, Mäntylä R, Kaste M, Erkinjuntti T.

J Stroke Cerebrovasc Dis. 2007 Nov-Dec;16(6):251-8.

PMID:
18035242
18.

Remote thalamic microstructural abnormalities related to cognitive function in ischemic stroke patients.

Fernández-Andújar M, Doornink F, Dacosta-Aguayo R, Soriano-Raya JJ, Miralbell J, Bargalló N, López-Cancio E, Pérez de la Ossa N, Gomis M, Millán M, Barrios M, Cáceres C, Pera G, Forés R, Clemente I, Dávalos A, Mataró M.

Neuropsychology. 2014 Nov;28(6):984-96. doi: 10.1037/neu0000087.

PMID:
24885449
19.

Predicting future brain tissue loss from white matter connectivity disruption in ischemic stroke.

Kuceyeski A, Kamel H, Navi BB, Raj A, Iadecola C.

Stroke. 2014 Mar;45(3):717-22. doi: 10.1161/STROKEAHA.113.003645.

20.

Frontal lobe atrophy is associated with small vessel disease in ischemic stroke patients.

Chen Y, Chen X, Xiao W, Mok VC, Wong KS, Tang WK.

Clin Neurol Neurosurg. 2009 Dec;111(10):852-7. doi: 10.1016/j.clineuro.2009.08.019.

PMID:
19744770
Items per page

Supplemental Content

Support Center